Home » Volumes » Volume 50 July/August 2017 » Wade’s histoid leprosy in a 14-year-old teenage boy

Wade’s histoid leprosy in a 14-year-old teenage boy

Renata Borges Fortes da Costa Figueira1 Karen Fernandes de Oliveira1 Luciana Borges de Souza1 Gustavo Henrique Soares Takano1 Jorgeth de Oliveira Carneiro da Motta1 Izelda Maria Carvalho Costa1

1Serviço de Dermatologia, Hospital Universitário de Brasília, Brasília, DF, Brasil.

DOI: 10.1590/0037-8682-0262-2016

He had not undergone prior treatment with anti-leprosy drugs, which accentuates the relevance of this case report.


Wade’s histoid leprosy (HL) is a rare variant of multibacillary leprosy, with characteristic clinical, immunologic, histopathologic, and bacteriologic features. It is associated with resistance to sulfa drugs or polychemotherapy and is rarely observed in patients who have not undergone prior treatment. Clinically, HL resembles keloid or dermatofibroma. Furthermore, HL is rare in children and is difficult to diagnose even by experts. This report describes a case of HL in a 14-year-old Brazilian boy, who presented with multiple nodular and tumor-like lesions, simulating keloids. He had not undergone prior treatment with anti-leprosy drugs, which accentuates the relevance of this case report.

Keywords: Histoid leprosy; Keloid; Multibacillary leprosy


Histoid leprosy is a very rare clinicopathological variant of leprosy, which is very difficult to diagnose due to different clinical and histopathological findings that mimic a fibromatous disorder. Histoid leprosy is a very rare clinicopathological variant of leprosy in childhood. It is important that health professionals recognize atypical leprosy presentations in order to perform appropriate treatment and to prevent physical damage and psychological suffering in these children.


A 14-year-old male patient, resident in Planaltina de Goiás/GO, presented with multiple keloid-simulating nodules, distributed over the left inner forearm (Figure 1), of 2-years duration. Subsequently, the face and lower limbs were involved. There was no history of prior treatment with anti-leprosy drugs and he denied any family history of leprosy.

FIGURE 1 Keloid nodules over the left forearm. 

Upon neurological examination, a thickening of the ulnar nerves without signs of neuritis and bilateral plantar hypoesthesia with a disability degree of 1 were noted. The auricular, radial, median, posterior tibial, and fibular nerves did not exhibit signs of thickening or pain, while the muscular strength of the upper and lower limbs was preserved, with no change in palmar sensitivity.

A histopathology examination revealed a lesion compatible with a dermatofibroma. The patient refused taking any drugs or surgical treatment at any health center or public or private hospitals where he had sought prior assistance, until he was referred to our dermatology department. Following examination at our department, the patient was diagnosed with multibacillary leprosy, Wade’s histoid variant.

The differential diagnosis included neurofibroma, leishmaniasis, and dermatofibroma. Bacteriologic examination of slit skin smear revealed a bacteriologic index of 4,25 +. Histopathology of the nodules showed a nodular and well-circumcised proliferation of spindle-shaped histiocytes, arranged in a storiform pattern in the upper dermis (Figure 2). Fite-Faraco stain demonstrated cells packed with numerous acid-fast bacilli (Figure 3). Based on these features, the diagnosis of histoid leprosy (HL) was confirmed, and the patient was treated with multidrug therapy (MDT). At the end of the 12-month treatment period, a partial reduction was noted in the nodules and in the bacilloscopy result indicators; treatment was deemed unsatisfactory. Thus, the decision was taken to prolong treatment with MDT for up to 24 months. The patient recently completed 16 months of treatment, showing progressive regression of the nodules.

FIGURE 2 Skin biopsy: nodular proliferation of spindle-shaped histiocytes in the dermis. 

FIGURE 3 Fite-Faraco staining: numerous alcohol-acid-resistant bacilli isolated and grouped together. 


Histoid leprosy is a rare type of multibacillary leprosy (MB), with specific clinical, histopathologic, bacteriologic, and immunological features1. It was described by Wade in 1963 and it is associated with resistance to sulfa drugs or polychemotherapy. It is rarely observed in patients who have not undergone prior treatment24, which reinforces the importance of this case report.

The etiopathogenesis of HL is not well understood5. However, it has been suggested to occur as a result of the action of drug-resistant mutant bacilli, or due to a decrease in cellular systemic immunity, with corresponding increase in local cellular and humoral immunity6. Efforts to restrict the disease or its spread are based on these findings5.

The average age of infection is between 21 and 40 years7; HL rarely occurs in childhood7.

Clinically it is characterized by cutaneous and/or subcutaneous nodules and papules, which are firm, skin-colored to yellowish-brown, emanating from an apparently normal skin6,7. These nodules resemble keloid or dermatofibroma. The lesions are usually located on the posterior and lateral areas of the arms, buttocks, thighs, dorsum of the hands, lower part of the back, and over the elbows and knees69. The palms and soles are usually not affected10. The keloid-simulating lesions in this patient highlight the clinically compatible nature of this disease with the histoid form.

Histoid leprosy, especially presenting as keloids and dermatofibroma, clinically simulates neurofibroma, xanthoma, sarcoidosis, cutaneous metastasis, diffuse cutaneous leishmaniasis, lobomycosis5, molluscum contagiosum7 and a papulonodular variant of secondary syphilis10.

The circumscribed nature of the lesion, the predominance of spindle-shaped cells, and the morphology of histoidbacilli are distinctive features in the histopathology of HL8,9. The lesion consists of fusiform histiocytes arranged in a whorled, crisscross, or storiform pattern9. These histiocytes resemble fibroblasts and the morphology of the lesions mimics neoplasms8, like dermatofibroma and neurofibroma. The acid-fast bacilli are longer than ordinary lepra bacilli and they are not found in globi formation8,9. Furthermore, the Wade variant is essentially underpinned by the demonstration of alcohol-acid-resistant bacilli that are isolated and grouped together.

The histopathologic similarity of a dermatofibroma-like lesion explains why the uncritical observation of some practicing pathologists or their unfamiliarity with leprosy biopsies may result in misdiagnoses, such as in the present case. This is common in both private and public pathology laboratories.

Once the clinical appearance of a histoid leproma resembles a dermatofibroma or keloid, many specialist physicians fail to suspect HL. This phenomenon has increasingly been observed recently, since leprosy studies have been neglected by several dermatologists.

While specialists encounter difficulties in diagnosing leprosy, it is a more serious challenge for professionals who operate within the primary care system. This underlines the important role of renowned centers, in training and enhancing the awareness of professionals in the health system, thereby, equipping primary care providers with the ability to suspect unusual clinical cases like this one.

Once microorganisms reach a high bacillary load, the host acts as a source of reservoir9,11,12and spreads the disease. Moreover, children with delayed diagnosis and appropriate treatment are faced with various degrees of incapacity, which compromises their future working capacity.

In addition, the impact of leprosy on children goes beyond physical damage, as it also entails psychological suffering due to the prejudice and stigma associated with the disease. The presence of lesions in visible areas, including the face and upper limbs, led to this adolescent avoiding social contact, demonstrating how the disease, though curable today, is still associated with widespread rejection and discrimination.


1. Palit A, Inamada ACA. Histoid leprosy as reservoir of the disease; a challenge to leprosy elimination. Lepr Rev. 2007;78(1):47-9. [ Links ]

2. Daxbacher ELR, Souza G, Jeunon T. Hanseníase históide: relato de caso revisando as características clínico-patológicas e considerações atuais. Hansen Int. 2015;40(Suppl 1): 67. [ Links ]

3. Nair SP, Kumar GN. Clinical and histopathological study of histoid leprosy. Int J Dermatol. 2013;52(5):580-6. [ Links ]

4. Kaur I, Dogra S, De D, Saikia UN. Histoid leprosy: a retrospective study of 40 cases from India. B J Dermatol. 2009;160(2):305-10. [ Links ]

5. Schettini APM, Eiras JC, Cunha MGS, Tubilla LHM, Sardinha JCG. Hanseníase históide de localização restrita. An Bras Dermatol. 2008;83(5):470-2. [ Links ]

6. Sehgal V, Aggarwal A, Srivastava G, Sharma N, Sharma S. Evolution of histoid leprosy (de novo) in lepromatous (multibacillary) leprosy. Int J Dermatol. 2005;44(7):576-8. [ Links ]

7. Chander R, Jabeen M, Malik M. Molluscum contagiosum-like lesions in histoid leprosy in a 10-yearold indian boy. Pediatr Dermatol. 2013;30(6):261-2. [ Links ]

8. Sehgal VN, Srivastava G, Singh N, Prasad PVS. Histoid leprosy: the impact of the entity on the postglobal leprosy elimination era. Int J Dermatol . 2009;48(6):603-10. [ Links ]

9. Gupta SK. Histoid leprosy: review of the literature. Int J Dermatol . 2015;54(11):1283-8. [ Links ]

10. Pandhi D, Reddy BSN, Khurana N, Agarwal S. Nodular syphilis mimicking histoid leprosy. J Eur Acad Dermatol Venereol. 2005;19(2):255-69. [ Links ]

11. Andrade PJS, Messias SSND, Ferreira PCBO, Sales AM, Machado AM, Nery JAC. Histoid leprosy: a rare exuberant case. An Bras Dermatol . 2015;90(5):756-7. [ Links ]

12. Sehgal VN, Srivastava G, Singh N. Histoid leprosy: histopathological connotations’ relevance in contemporary context. Am J Dermatopathol. 2009;31(3):268-71. [ Links ]

Received: July 26, 2016; Accepted: March 28, 2017

Corresponding author: Dra. Renata Borges Fortes da Costa Figueira. e-mailfigueirarenata@hotmail.com

Conflict of interest: The authors declare that there is no conflict of interest.